Back to search
Corticobasal Degeneration (CBD)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Corticobasal Degeneration (CBD) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Corticobasal Degeneration (CBD) trials you may qualify forThis study is an observational, prospective genetic study. It aims to obtain DNA for research and testing from patients with PSP, CBS, MSA, and related neurolog…
Previous preliminary results are sufficiently impressive to suggest that tDCS stimulation does have the potential to improve motor function when that ability is…
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) represents the formalized integration of ARTFL (U54 NS092089; funded through 2019) and LEF…
The primary goal of this study is to investigate inflammation and white matter damage in corticobasal syndrome and determine whether these processes are related…
A quantitative evaluation method was developed for Parkinson's disease and other atypical parkinonism by integrating an innovative motor paradigm with perceptio…
The primary objective of this study is to enroll an observational cohort of approximately 60 patients with PSP over the course of 24 months using a multicenter…
The goal of this study is to identify the most reliable methods of analysis for tracking CBD, PSP, and o/vPSP over time. The results from this study may be used…
The objective of the ADDIA clinical Proof-of-Performance study is to validate the performance of ADDIA' blood biomarkers for diagnosis of Alzheimer's disease (A…